Cite

HARVARD Citation

    Kou, J. et al. (2022). A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin. Psychological medicine. 52 (10), pp. 1959-1968. [Online]. 
  
Back to record